New York, New York--(Newsfile Corp. - March 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alight, Inc. (NYSE: ALIT) between November 12, 2024 and February 18, 2026, both dates inclusive (the "Class Period"), of the important May 15, 2026 lead plaintiff deadline.SO WHAT: If you purchased Alight common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrang ...

New York, New York--(Newsfile Corp. - March 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers Class A common stock of Snowflake Inc. (NYSE: SNOW) between June 27, 2023 and the close of the market on February 28, 2024 (4:00 p.m. ET), inclusive (the "Class Period"), of the important April 27, 2026 lead plaintiff deadline.SO WHAT: If you purchased Snowflake Class A common stock during the Class Period you may be entitled to compensation without payment of any out of pocket ...

Mkango Resources Limited Announces RetailBook Offer THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR"). NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN ANY JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY ...

NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of monday.com Ltd. (NASDAQ: MNDY) between September 17, 2025 and February 6, 2026, both dates inclusive (the “Class Period”), of the important May 11, 2026 lead plaintiff deadline. SO WHAT: If you purchased monday.com common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrange ...

Group 1 - A class action lawsuit has been announced by Rosen Law Firm on behalf of purchasers of Coty Inc. common stock between November 5, 2025, and February 4, 2026 [1] - Investors who purchased Coty common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - The lawsuit alleges that Coty made false and misleading statements regarding its slowing growth in the beauty market, particularly in the Consumer Beauty segment and Prestige fragrance segment [5] Group 2 - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4] - The firm has been recognized for its success in securities class action settlements, being ranked No. 1 by ISS Securities Class Action Services in 2017 and consistently in the top 4 since 2013 [4] - Investors are encouraged to select qualified counsel with a proven history in leadership roles within securities litigation [4]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Chanson International Holding due to allegations of materially misleading business information issued to the investing public [1]. Group 1: Investigation Details - The investigation is focused on potential civil securities claims against Chanson International Holding (NASDAQ: CHSN) [3]. - Shareholders who purchased Chanson International securities may be entitled to compensation through a contingency fee arrangement, meaning no out-of-pocket fees or costs for them [2]. Group 2: Class Action Information - Rosen Law Firm is preparing a class action to seek recovery of investor losses related to the alleged misleading information [2]. - Interested parties can join the prospective class action by visiting the provided link or contacting the firm directly [2]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at that time [4]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Lakeland Industries, Inc. during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Lakeland securities between December 1, 2023, and December 9, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by April 24, 2026 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Case Background - The lawsuit alleges that Lakeland's management made false and misleading statements regarding the performance of its Pacific Helmets and Jolly businesses, including issues such as shipping delays and production problems [5]. - It is claimed that the defendants overstated the positive impact of these businesses on Lakeland's financial results and the overall strength of operations [5]. - The lawsuit also highlights that Lakeland's financial results were deteriorating due to tariff-related challenges and other operational issues, leading to unreliable financial guidance [5]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4]. - Founding partner Laurence Rosen has received recognition as a leading figure in the plaintiffs' bar, further establishing the firm's credibility [4].

Group 1 - The Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Hitek Global Inc. due to allegations of materially misleading business information issued by the company [1][3] - Shareholders who purchased Hitek securities may be entitled to compensation through a class action without any out-of-pocket fees, as the Rosen Law Firm is preparing to seek recovery of investor losses [2] - The firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4] Group 2 - The Rosen Law Firm has a history of significant recoveries for investors, including over $438 million secured in 2019 and being ranked No. 1 for securities class action settlements in 2017 [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Soleno Therapeutics, Inc. during the specified Class Period of the upcoming lead plaintiff deadline on May 5, 2026 [1] Group 1: Class Action Details - Investors who bought Soleno common stock between March 26, 2025, and November 4, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6] - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions [4] Group 2: Case Allegations - The lawsuit alleges that Soleno made false or misleading statements regarding the safety of its Phase 3 clinical trial program for diazoxide choline extended-release tablets (DCCR), particularly concerning safety risks related to fluid retention [5] - It is claimed that the administration of DCCR for treating hyperphagia in individuals with Prader-Willi syndrome posed greater safety risks than disclosed, affecting its commercial viability and leading to potential adverse events post-launch [5]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of monday.com Ltd. during the specified class period of the upcoming lead plaintiff deadline on May 11, 2026 [1]. Group 1: Class Action Details - Investors who bought monday.com common stock between September 17, 2025, and February 6, 2026, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - To serve as lead plaintiff, individuals must file a motion with the court by May 11, 2026 [3]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, and many attorneys at the firm have received accolades from Lawdragon and Super Lawyers [4]. Group 3: Case Allegations - The lawsuit alleges that monday.com made false or misleading statements regarding its revenue growth outlook, including decelerating growth and extended sales cycles [5].